BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20509416)

  • 1. Mesalamine lung toxicity.
    Jain N; Petruff C; Bandyopadhyay T
    Conn Med; 2010 May; 74(5):265-7. PubMed ID: 20509416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesalamine-induced lung toxicity.
    Bitton A; Peppercorn MA; Hanrahan JP; Upton MP
    Am J Gastroenterol; 1996 May; 91(5):1039-40. PubMed ID: 8633548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalamine-induced lung injury in a patient with ulcerative colitis and a confounding autoimmune background: a case report.
    Actis GC; Ottobrelli A; Baldi S; Scappaticci E; Modena V; Fusaro E; Mengozzi G; Rizzetto M
    Mt Sinai J Med; 2005 Mar; 72(2):136-40. PubMed ID: 15770345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eosinophilic pneumonia caused by mesalazine. Report of one case].
    Pérez C; Errázuriz I; Brockmann P; González S; Cofré C
    Rev Med Chil; 2003 Jan; 131(1):81-4. PubMed ID: 12643224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interstitial pneumonia related to mesalamine].
    Lamsiah T; Moudden K; Baaj M; Hadri L
    Gastroenterol Clin Biol; 2010 Mar; 34(3):224-6. PubMed ID: 20299168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesalamine-induced chest pain: a case report.
    Amin HE; Della Siega AJ; Whittaker JS; Munt B
    Can J Cardiol; 2000 May; 16(5):667-9. PubMed ID: 10833545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesalazine-induced eosinophilic variant of Wegener's granulomatosis in an ulcerative colitis patient.
    Fayaz M; Sultan A; Nawaz M; Sultan N
    J Ayub Med Coll Abbottabad; 2009; 21(4):171-3. PubMed ID: 21067054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
    Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mesalamine-induced hypersensitivity pneumonitis].
    Zamir D; Weizman J; Zamir C; Fireman Z; Weiner P
    Harefuah; 1999 Jul; 137(1-2):28-30, 87, 86. PubMed ID: 10959271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute alveolitis due to mesalazine].
    Lagler U; Schulthess HK; Kuhn M
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1332-4. PubMed ID: 1411390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of mesalazine-induced pleuritis with hemophagocytic findings].
    Yamauchi K; Takeda H; Kobayashi K; Watanabe K; Machida Y; Suzuki H
    Nihon Kokyuki Gakkai Zasshi; 2005 Sep; 43(9):518-22. PubMed ID: 16218420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of lung injury induced by long-term administration of mesalazine].
    Shindoh Y; Horaguchi R; Hayashi K; Suda Y; Iijima H; Shindoh C
    Nihon Kokyuki Gakkai Zasshi; 2011 Nov; 49(11):861-6. PubMed ID: 22171492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily mesalamine (Lialda) for ulcerative colitis.
    Med Lett Drugs Ther; 2007 Mar; 49(1257):25-6. PubMed ID: 17375030
    [No Abstract]   [Full Text] [Related]  

  • 17. Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis.
    Stelts S; Taylor MH; Nappi J; Van Bakel AB
    Ann Pharmacother; 2008 Jun; 42(6):904-5. PubMed ID: 18430794
    [No Abstract]   [Full Text] [Related]  

  • 18. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
    Marshall JK; Irvine EJ
    Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature.
    Sviri S; Gafanovich I; Kramer MR; Tsvang E; Ben-Chetrit E
    J Clin Gastroenterol; 1997 Jan; 24(1):34-6. PubMed ID: 9013348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two cases of drug-induced intrathoracic lesions caused by mesalazine in patients with ulcerative colitis].
    Machida H; Shinohara T; Hatakeyama N; Inayama M; Hosokawa E; Ogushi F
    Nihon Kokyuki Gakkai Zasshi; 2011 Jul; 49(7):538-42. PubMed ID: 21842693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.